Schafer, Sebastian
Viswanathan, Sivakumar
Widjaja, Anissa A.
Lim, Wei-Wen
Moreno-Moral, Aida
DeLaughter, Daniel M.
Ng, Benjamin
Patone, Giannino
Chow, Kingsley
Khin, Ester
Tan, Jessie
Chothani, Sonia P.
Ye, Lei
Rackham, Owen J. L.
Ko, Nicole S. J.
Sahib, Norliza E.
Pua, Chee Jian
Zhen, Nicole T. G.
Xie, Chen
Wang, Mao
Maatz, Henrike
Lim, Shiqi
Saar, Kathrin
Blachut, Susanne
Petretto, Enrico
Schmidt, Sabine
Putoczki, Tracy
Guimarães-Camboa, Nuno
Wakimoto, Hiroko
van Heesch, Sebastiaan
Sigmundsson, Kristmundur
Lim, See L.
Soon, Jia L.
Chao, Victor T. T.
Chua, Yeow L.
Tan, Teing E.
Evans, Sylvia M.
Loh, Yee J.
Jamal, Muhammad H.
Ong, Kim K.
Chua, Kim C.
Ong, Boon-Hean
Chakaramakkil, Mathew J.
Seidman, Jonathan G.
Seidman, Christine E.
Hubner, Norbert
Sin, Kenny Y. K.
Cook, Stuart A.
Article History
Received: 22 March 2017
Accepted: 2 November 2017
First Online: 13 November 2017
Competing interests
: S.A.C. and S.Scha. are co-inventors of the patent application (WO2017103108) ‘Treatment of fibrosis’. S.A.C. and S.Scha. are co-founders and shareholders of Enleofen Bio PTE LTD, a company that develops therapeutics based on findings described in this manuscript.